Opinion statement
-
Pancreatic cystic neoplasms are uncommon, but are being detected at an increased rate in the current era of sophisticated abdominal imaging. The selection of appropriate treatment depends on the ability to distinguish benign from malignant cysts. The most common clinical mistake is to treat a cystic neoplasm as a benign pseudocyst.
-
The identification of a cyst as a cystic neoplasm should be suspected on clinical grounds, but the differentiation from a benign cyst is often difficult based on clinical features and imaging alone. Analysis of cystic fluid for tumor markers and cytology should be considered, using newer approaches such as endoscopic ultrasound-guided fine needle aspiration (FNA), in those patients in whom this information may guide appropriate therapy.
-
Surgical excision of a cystic pancreatic neoplasm is the treatment of choice in patients fit for surgery. Inappropriate treatment of these lesions as pseudocysts, by radiographic, endoscopic, or surgical drainage, is to be avoided. Resection of the lesion should be seriously considered even in the absence of symptoms, as these lesions have malignant potential and are often curable.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Fernandez-del Castillo C, Warshaw AL: Cystic tumors of the pancreas. Surg Clin North Am 1995, 75:1001–1016.
Carr-Locke DL: Mucin hypersecreting neoplasms. Ann Oncol 1999, 10(suppl 4):99–103.
Lundstedt C, Dawiskiba S: Serous and mucinous cystadenoma/cystadenocarcimoma of the pancreas. Abdom Imaging 2000, 25:201–206.
Johnson CD, Stephens DH, Charboneau JW, et al.: Cystic pancreatic tumors: CT and sonographic assessment. AJR 1988, 151:1133–1188.
Warshaw AL, Compton CC, Lewandrowski K, et al.: Cystic tumors of the pancreas: new clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 1990, 21:432–445. This landmark paper thoroughly describes the clinical, radiographic, and pathological characteristics of the different cystic neoplasms.
Carlson SK, Johnson CD, Brandt KR, et al.: Pancreatic cystic neoplasms: the role and sensitivity of needle aspiration and biopsy. Abdom Imaging 1998, 23:387–393.
Soyer P, Rabenandrasan A, Van Beers B, et al.: Cystic tumors of the pancreas: Dynamic CT Studies. J Comput Assist Tomogr 1994, 18:420–426. This review reassessed the common dynamic CT manifestations of cystic tumors of the pancreas. The authors found that dynamic CT findings are useful for differentiating serous cystadenomas and mucin-producing duct ectasias from other cystic tumors of the pancreas, and benign from malignant tumors.
Koito K, Namieno T, Nagakawa T, et al.: Solitary cystic tumor of the pancreas: EUS-pathologic correlation. Gastrointest Endosc 1997, 45:268–276. The authors describe an EUS classification scheme dependent on the presence or absence of tumor protruding into the cyst, the relative thickness of the wall of the cysts and intervening septa, and the presence or absence of small cystic cavities. The authors suggest that non-neoplastic tumors typically are identified as a simple cyst or a cyst having only thin septa within it and thus highlight the importance of EUS in evaluating pancreatic cysts.
Gress F, Gottlieb K, Cummings O, et al.: Endoscopic ultrasound characteristics of mucinous cystic neoplasms of the pancreas. Am J Gastroenterol 2000, 95:961–965.
Hammel P, Levy P, Voitot H, et al.: Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology 1995, 108:1230–1235.
Lewandrowski KB, Southern J, Pins MR, et al.: Cyst fluid analysis in the differential diagnosis of pancreatic cysts. Ann Surg 1993, 217:41–47. This was the original study that brought cystic fluid analysis to the forefront. Cystic fluid sampling for viscosity, amylase, CEA, CA-125, and cytology, provided preoperative classification of pseudocysts, serous cystadenomas and mucinous tumors.
Erickson RA, Sayage-Rabie L, Avots-Avotins A: Clinical utility of endoscopic ultrasound-guided fine needle aspiration. Acta Cytol 1997, 41:1647–1653.
Wiersema MJ, Vilmann P, Giovannini M, et al.: Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997, 112:1087–1095. This large, multicenter study provides a thorough evaluation of the characteristics of EUS-guided FNA from different lesions. A 0.5% complication rate was noted overall in 554 lesions. Eighteen patients with pancreatic cystic lesions underwent EUS-guided FNA. Two febrile episodes occurred after EUS-FNA of cystic lesions, requiring antibiotics.
Grandval P, Picon M, Coste P, et al.: Infection of submucosal tumor after endosonography — guided needle biopsy. Gastroenterol Clin Biol 1999, 23:566–568.
Alles AJ, Warshaw AL, Southern JF, et al.: Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts. Ann Surg 1994, 219:131–134.
Yang JM, Southern JF, Warshaw AL, et al.: Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadeocarcinomas from benign cystic tumors and pseudocysts. Am J Surg 1996, 171:26–29.
Sperti C, Pasquali C, Pedrazzoli S, et al.: Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from non-mucinous pancreatic cysts. Am J Gastroenterol 1997, 92:672–675.
Centeno BA, Warshaw AL, Mayo-Smith W, et al.: Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates. Acta Cytol 1997, 4:972–980.
Dodd LG, Farrell TA, Layfield LJ: Mucinous cystic tumor of the pancreas: an analysis of FNA characteristics with an emphasis on the spectrum of malignancy associated features. Diagn Cytopathol 1995, 12:113–119.
Jimenez RE, Warshaw AL, Rattner DW, et al.: Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg 2000, 135:409–415. Based on a staging laparoscopy combined with spiral CT, patients were stratified into three treatment groups that correlated with treatment opportunity and subsequent survival. Thirty-one percent of patients were found during laparoscopy to have unsuspected metastases, and thus were palliated without further resection. In this landmark study, the authors emphasize that laparoscopic staging can help focus aggressive treatment on patients with pancreatic cancer who might benefit most.
Schachter PP, Avni Yona, Gvirz F, et al.: The impact of laparoscopy and laparoscopic ultrasound on the management of pancreatic cystic lesions. Arch Surg 2000, 135:260–264.
Horvath KD, Chabot JA: An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 1999, 178:269–274. An excellent outcomes-oriented study highlighting the merits of an aggressive surgical approach to all cystic neoplasms of the pancreas. The authors suggest that all patients with cystic neoplasm, if medically fit to tolerate surgery, should undergo surgery because 1) preoperative differentiation of a benign versus malignant tumor is unreliable; 2) potential adverse consequences of nonresectional therapy are significant; 3) perioperative morbidity and mortality of pancreatic surgery is low; and 4) prognosis with curative resection is excellent.
ReMine SG, Frey D, Rossi RL, et al.: Cystic noplasms of the pancreas. Arch Surg 1987, 122:443–446.
Warshaw A, Rattner DW, Fernandez-del Castillo C, et al.: Middle segment pancreatectomy: a novel technique for conserving pancreatic tissue. Arch Surg 1998, 133:327–331. The authors describe a new surgical technique of middle pancreatectomy in 12 patients with neck and body lesions of the pancreas. This procedure would be of great benefit in patients who might not tolerate extensive pancreatic tissue removal.
Talamini M, Moesinger R, Yeo CJ, et al.: Cystadenomas of the pancreas: is enucleation an adequate operation? Ann Surg 1998, 227:896–903.
Le Borgne J, De Calan L, Partensky C: Cystadenomas and cystadenocarcinoma of the pancreas: a multi-institutional retrospective study of 398 cases. Ann Surg 1999, 230:152–161. The authors propose that most lesions should undergo an aggressive surgical removal. Small, asymptomatic lesions can be observed safely.
Rivera J, Fernandez-del Castillo C, Pins M, et al.: Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms: a single malignant clinicopathologic entity. Ann Surg 1997, 225:637–644.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mishra, G., Forsmark, C.E. Cystic neoplasms of the pancreas. Curr Treat Options Gastro 3, 355–361 (2000). https://doi.org/10.1007/s11938-000-0050-7
Issue Date:
DOI: https://doi.org/10.1007/s11938-000-0050-7